DIN 02245977 — RECOMBIVAX HB 40 MCG
RECOMBIVAX HB is a suspension of Hepatitis B Surface Antigen marketed by MERCK CANADA INC. The full Hepatitis B Surface Antigen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02245977
- Brand name
- RECOMBIVAX HB
- Active ingredient
- Hepatitis B Surface Antigen
- Strength
- 40 MCG
- Dosage form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Manufacturer
- MERCK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Recombinant viral subunit vaccine
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hepatitis B Surface Antigen products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02487020 | ENGERIX-B | 10 MCG | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 02487039 | ENGERIX-B | 20 MCG | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 02561484 | RECOMBIVAX HB | 10 MCG | SOLUTION | MERCK CANADA INC | MARKETED |
| 02561476 | RECOMBIVAX HB | 5 MCG | SOLUTION | MERCK CANADA INC | MARKETED |